首页> 外国专利> PURIFIED EXTRACT (ATS2) SEPARATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR SUBINTEGRUM WITH HIGH CONTENT OF ACTIVE INGREDIENT, ITS PRODUCTION AND COMPOSITION CONTAINING THE ABOVE EXTRACT AS AN ACTIVE INGREDIENT TO PREVENT OR TREAT INFLAMMATION, ALLERGIES AND ASTHMA

PURIFIED EXTRACT (ATS2) SEPARATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR SUBINTEGRUM WITH HIGH CONTENT OF ACTIVE INGREDIENT, ITS PRODUCTION AND COMPOSITION CONTAINING THE ABOVE EXTRACT AS AN ACTIVE INGREDIENT TO PREVENT OR TREAT INFLAMMATION, ALLERGIES AND ASTHMA

机译:纯化的提取物(ATS2)是从假单胞菌属的var子积分中分离出来的,具有高含量的活性成分,其生产和成分均包含上述提取物,是预防或治疗发炎,变态反应和哮喘的有效成分

摘要

FIELD: pharmaceutical industry.;SUBSTANCE: invention relates to the pharmaceutical industry, in particular to an extract of Pseudolysimachion rotundum var subintegrum for the prevention and treatment of inflammatory disease. Pseudolysimachion rotundum var subintegrum extract for the prevention and treatment of inflammatory diseases, containing 30–60 % (w/w) veprozide, 0.5–10 % (w/w) veratric acid, 2–20 % (w/w) catalposide, 1–10 % (w/w) picroside II, 1–10 % (w/w) isovanyloylcate and 2–20 % (w/w) 6-O-veratroylcatalpol based on the total weight of the extract (100 %) Pseudolysimachion rotundum var subintegrum, where the specified extract obtained by the method, including: adding aqueous ethanol to the dried Pseudolysimachion rotundum var subintegrum at the 1st stage; carrying out the extraction with cold water and then carrying out the extraction under reflux; repeating these steps to obtain the 1st extract in the 2nd stage; suspending said 1st extract in approximately 1–5 times the volume of water to obtain a suspended extract in step 3; adding 1–10 times the volume of butanol, fractionating to obtain an aqueous layer and a butanol layer and collecting the butanol layer to obtain said purified extract, fractionated using butanol (ATS1), at the 3rd stage and purification of the specified purified extract, fractionated using butanol (ATS1), using reverse-phase distribution chromatography using a stationary phase selected from a stationary phase based on silica gel or a stationary phase based on polymer, and a mobile phase selected from the group consisting of water, acetonitrile, methanol, ethanol, butanol, tetrahydrofuran (THF), and mixtures thereof, under certain conditions. Method of obtaining the extract, as well as a pharmaceutical composition.;EFFECT: extract described above has a pronounced anti-inflammatory effect.;3 cl, 15 dwg, 8 ex, 10 tbl
机译:技术领域本发明涉及制药工业,尤其涉及用于预防和治疗炎性疾病的圆假假单胞菌变种的提取物。用于预防和治疗炎性疾病的假圆形腐皮变种提取物,其中含有30-60%(w / w)的维普罗嗪,0.5-10%(w / w)的维甲酸,2-20%(w / w)的苦瓜甙,1基于提取物的总重量(100%)的圆形假单胞菌–10%(w / w)山梨糖苷II,1–10%(w / w)异戊酰基和2–20%(w / w)6-O-藜芦醇var subintegrum,其中通过该方法获得的指定提取物,包括:在第一阶段将乙醇水溶液添加到干燥的假圆圆变种var subintegrum中;用冷水萃取,然后在回流下萃取;重复这些步骤以获得第二阶段的第一提取物;将第一种提取物悬浮在大约1-5倍的水量中,以在步骤3中获得悬浮的提取物;在丁醇中添加1-10倍体积的丁醇,分馏以获得水层和丁醇层,收集丁醇层以获得所述纯化的提取物,在第三阶段使用丁醇(ATS1)进行分馏并纯化指定的纯化提取物,使用丁醇(ATS1)进行分馏,使用反相固定色谱,该固定相选自硅胶固定相或聚合物固定相,流动相选自水,乙腈,甲醇,乙醇,丁醇,四氢呋喃(THF)及其混合物。获得提取物的方法以及药物组合物;效果:上述提取物具有明显的抗炎作用; 3 cl,15 dwg,8 ex,10 tbl

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号